U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07402317) titled 'Trimodality Bladder Preservation' on Feb. 01.
Brief Summary: The aim of this study is To evaluate the outcomes of patients with muscle invasive bladder cancer managed by trimodal therapy", Neoadjuvant chemotherapy( NAC) followed by Transurethral resection of the bladder tumor then Radiotherapy, for bladder preservation and capability to reach the goal of better quality of life, compared to radical cystectomy with assessment of factors that may predict treatment response, risk of recurrences and (disease- free and over all)survival of such patients...
Study Start Date: Dec. 11, 2018
Study Type: INTERVENTIONAL
Condition:
Bladder C...